CHRS   $0.88  3.53% Market Closed After Close 0.8744 -0.64%

Coherus BioSciences Inc
Total Cash 159.24M
totalCashPerShare 1.382
EBITDA -142.29M
Total Debt 269.70M
quickRatio 1.021
currentRatio 1.205
Total Revenue 308.13M
debtToEquity
Revenue/Share 2.819
ROA -0.16049999
ROE
grossProfits
freeCashflow 64.51M
operatingCashflow -54.27M
earningsGrowth
revenueGrowth 0.107
grossMargins 0.41511002
ebitdaMargins -0.46178
operatingMargins -0.31563
profitMargins -0.09522
enterpriseValue 215.31M
forwardPE -3.87
floatShares 103.30M
sharesOutstanding 115.21M
sharesShort 27.96M
sharesShortPriorMonth 25.15M
dateShortInterest
sharesPercentSharesOut 0.24%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.73%
Short Ratio help_outline 12.98%
shortPercentOfFloat 0.28%
impliedSharesOutstanding
bookValue -0.73
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -29.34M
trailingEps -0.38%
forwardEps -0.23%
enterpriseToEbitda -1.51
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 3Q 2024
institutionsCount 182
lastUpdated Oct. 16, 2024, 7:23 p.m.